We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.4B
AUM Growth
-$406M
Cap. Flow
-$163M
Cap. Flow %
-1.13%
Top 10 Hldgs %
24.27%
Holding
957
New
98
Increased
341
Reduced
353
Closed
82

Top Buys

Rank Stock Value
1
BZ icon
Kanzhun
BZ
+$45.9M
2
STKL
SunOpta
STKL
+$45M
3
ZTO icon
ZTO Express
ZTO
+$44.4M
4
JPM icon
JPMorgan Chase
JPM
+$39.9M
5
XIFR
XPLR Infrastructure LP
XIFR
+$36.1M

Top Sells

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$79.9M
2
MSFT icon
Microsoft
MSFT
+$58.5M
3
VERU icon
Veru
VERU
+$53.9M
4
PG icon
Procter & Gamble
PG
+$50.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37M

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Technology 26.5%
3 Financials 9.1%
4 Consumer Discretionary 8.02%
5 Industrials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACH
751
Accendra Health
ACH
$254M
$454K ﹤0.01%
33,879
-8,373
-20% -$150K
RDNT icon
752
RadNet
RDNT
$4.98B
$451K ﹤0.01%
19,563
-25,129
-56% -$546K
RETA
753
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$450K ﹤0.01%
+5,377
New +$316K
YELP icon
754
Yelp
YELP
$1.54B
$448K ﹤0.01%
15,843
+2,802
+21% +$84.3K
NYT icon
755
New York Times
NYT
$12.6B
$448K ﹤0.01%
12,508
+1,704
+16% +$62.8K
TBPH icon
756
Theravance Biopharma
TBPH
$873M
$444K ﹤0.01%
44,489
-38,713
-47% -$409K
OGN icon
757
Organon & Co
OGN
$3.56B
$443K ﹤0.01%
+20,486
New +$550K
ZD icon
758
Ziff Davis
ZD
$2B
$441K ﹤0.01%
6,135
+1,899
+45% +$156K
SYNH
759
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$438K ﹤0.01%
+13,373
New +$485K
NARI
760
DELISTED
Inari Medical, Inc. Common Stock
NARI
$438K ﹤0.01%
7,713
-5,096
-40% -$306K
ZIP icon
761
ZipRecruiter
ZIP
$339M
$438K ﹤0.01%
+29,854
New +$539K
PPLI
762
People Inc
PPLI
$3.12B
$436K ﹤0.01%
11,184
+1,611
+17% +$69K
SEM
763
DELISTED
Select Medical
SEM
$433K ﹤0.01%
33,774
-36,628
-52% -$539K
MODV
764
DELISTED
ModivCare
MODV
$431K ﹤0.01%
+5,571
New +$536K
VREX icon
765
Varex Imaging
VREX
$462M
$431K ﹤0.01%
25,735
-18,689
-42% -$356K
PCTY icon
766
Paylocity
PCTY
$7.75B
$430K ﹤0.01%
+2,352
New +$463K
EHC icon
767
Encompass Health
EHC
$11.3B
$430K ﹤0.01%
8,635
-7,025
-45% -$409K
PDCO
768
DELISTED
Patterson Companies, Inc.
PDCO
$430K ﹤0.01%
17,445
-13,737
-44% -$386K
AGIO icon
769
Agios Pharmaceuticals
AGIO
$2.08B
$426K ﹤0.01%
+20,160
New +$535K
AA icon
770
Alcoa
AA
$11.3B
$421K ﹤0.01%
10,743
-1,392
-11% -$67.1K
CCO icon
771
Clear Channel Outdoor Holdings
CCO
$1.22B
$421K ﹤0.01%
380,761
+15,219
+4% +$22.4K
BBWI icon
772
Bath & Body Works
BBWI
$3.97B
$420K ﹤0.01%
12,480
– –
PRVB
773
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$420K ﹤0.01%
18,922
-78,587
-81% -$986K
PHAT icon
774
Phathom Pharmaceuticals
PHAT
$928M
$419K ﹤0.01%
63,778
-19,579
-23% -$172K
ENOV icon
775
Enovis
ENOV
$1.74B
$419K ﹤0.01%
8,506
-7,922
-48% -$459K
29 30
31
32 33

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2023 Portfolio in Review

As of Q1 2023, Candriam SCA held 957 positions worth $14.4B, down 2.7% from $14.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q1 2023 filing shows 98 new, 341 increased, 353 reduced and 82 closed positions. Its largest new stake was Kanzhun: 2,106,130 shares worth $36.9M. The largest sale was Mercado Libre, an estimated $79.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2023 buy was Kanzhun: 2,106,130 shares worth $36.9M.
  • Candriam SCA added most to SunOpta in Q1 2023, an estimated $45M increase.
  • Candriam SCA's biggest Q1 2023 reduction was Mercado Libre, cutting an estimated $79.9M.
  • Candriam SCA fully exited Veru in Q1 2023, selling an estimated $53.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.4B portfolio in Q1 2023.
  • Candriam SCA opened 98 new positions and closed 82 in Q1 2023.
  • Candriam SCA's portfolio value fell 2.7% quarter-over-quarter to $14.4B.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.